NCT00882141

Brief Summary

The purpose of this study is to test the hypotheses that there are ethnic and genetic differences in the mechanisms and magnitude by which hypocaloric weight loss and aerobic exercise affect body composition, glucose, lipid, muscle and adipose tissue metabolism in overweight, insulin resistant postmenopausal women. This will be tested in a trial comparing the effects of weight loss vs. aerobic exercise plus weight loss on glucose, lipid, fat and muscle metabolism in overweight African American and Caucasian postmenopausal women.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
103

participants targeted

Target at P50-P75 for not_applicable obesity

Timeline
Completed

Started Mar 2002

Longer than P75 for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2002

Completed
6.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2008

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

April 15, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 16, 2009

Completed
Last Updated

January 13, 2010

Status Verified

January 1, 2010

Enrollment Period

6.8 years

First QC Date

April 15, 2009

Last Update Submit

January 11, 2010

Conditions

Keywords

ExerciseObesityInsulin Sensitivity

Outcome Measures

Primary Outcomes (2)

  • Glucose Clamp

    At 4-6 weeks

  • Fat biopsy

    At 4-6 weeks

Study Arms (2)

1

EXPERIMENTAL

Weight loss

Behavioral: Diet modification

2

EXPERIMENTAL

Exercise plus weight loss

Behavioral: Diet modificationBehavioral: Aerobic exercise

Interventions

Weight loss sessions are held by a registered dietitian for 1 hour once a week for 6-9 months; recommended caloric intake to elicit a weight loss of approximately 0.2-0.4 kg per week

Also known as: American Heart Association "Heart Healthy" diet
12

Treadmills and other aerobic exercise equipment 3 times a week for 6-9 months, beginning at low levels of VO2max and progressing in duration and intensity to more than 75% VO2max for 45 minutes

2

Eligibility Criteria

Age45 Years - 80 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female
  • yrs of age
  • Non-smoking for one year
  • BMI greater than 25 kg/m2 and less than 50 kg/m2
  • Menopause over 1 year
  • Caucasian or African American ethnicity

You may not qualify if:

  • Both groups
  • Currently being treated for active cancer
  • Type 1 diabetes; insulin treatment; poorly controlled (fasting blood sugar over 160 mg/dl)
  • Allergic to lidocaine or heparin
  • Untreated dyslipidemia, receiving triglyceride-lowering meds
  • Other systemic disorders that are not medically treated and stable
  • Taking beta-blockers, oral steroids, warfarin or any other medications interfering with fat/muscle metabolism that may not be safely discontinued temporarily for specific procedures (i.e. for 72 hours prior)
  • Abnormal liver or renal function; chronic pulmonary disease (on supplemental oxygen); anemia
  • MMSE (Mini-Mental State Examination) below 24, dementia or unstable clinical depression by exam
  • Women of ethnicity other than Caucasian or African American
  • Symptomatic heart disease, coronary artery disease, congestive heart failure, or uncontrolled hypertension unless medically stabilized
  • Abnormal response to exercise test (chest pain, significant arrhythmias, extreme shortness of breath, cyanosis, exercising blood pressure above 240/120mm Hg, or other contraindications to exercise)
  • Exercise plus weight loss group only
  • Medical history of CVD (cardiovascular disease) with symptoms limiting ability to exercise
  • Physical impairment limiting normal activity
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Maryland, VAMC

Baltimore, Maryland, 20705, United States

Location

Related Publications (11)

  • Berman DM, Rodrigues LM, Nicklas BJ, Ryan AS, Dennis KE, Goldberg AP. Racial disparities in metabolism, central obesity, and sex hormone-binding globulin in postmenopausal women. J Clin Endocrinol Metab. 2001 Jan;86(1):97-103. doi: 10.1210/jcem.86.1.7147.

    PMID: 11231984BACKGROUND
  • Ryan AS, Nicklas BJ, Berman DM. Racial differences in insulin resistance and mid-thigh fat deposition in postmenopausal women. Obes Res. 2002 May;10(5):336-44. doi: 10.1038/oby.2002.47.

    PMID: 12006632BACKGROUND
  • Nicklas BJ, Dennis KE, Berman DM, Sorkin J, Ryan AS, Goldberg AP. Lifestyle intervention of hypocaloric dieting and walking reduces abdominal obesity and improves coronary heart disease risk factors in obese, postmenopausal, African-American and Caucasian women. J Gerontol A Biol Sci Med Sci. 2003 Feb;58(2):181-9. doi: 10.1093/gerona/58.2.m181.

    PMID: 12586858BACKGROUND
  • Ryan AS, Nicklas BJ, Berman DM. Aerobic exercise is necessary to improve glucose utilization with moderate weight loss in women. Obesity (Silver Spring). 2006 Jun;14(6):1064-72. doi: 10.1038/oby.2006.122.

    PMID: 16861612BACKGROUND
  • Ryan AS, Serra MC, Goldberg AP. Metabolic Benefits of Prior Weight Loss with and without Exercise on Subsequent 6-Month Weight Regain. Obesity (Silver Spring). 2018 Jan;26(1):37-44. doi: 10.1002/oby.22032. Epub 2017 Oct 25.

  • Ortmeyer HK, Goldberg AP, Ryan AS. Exercise with weight loss improves adipose tissue and skeletal muscle markers of fatty acid metabolism in postmenopausal women. Obesity (Silver Spring). 2017 Jul;25(7):1246-1253. doi: 10.1002/oby.21877. Epub 2017 May 26.

  • Ge S, Ryan AS. Zinc-alpha2-glycoprotein expression in adipose tissue of obese postmenopausal women before and after weight loss and exercise + weight loss. Metabolism. 2014 Aug;63(8):995-9. doi: 10.1016/j.metabol.2014.04.013. Epub 2014 May 4.

  • Ryan AS, Ge S, Blumenthal JB, Serra MC, Prior SJ, Goldberg AP. Aerobic exercise and weight loss reduce vascular markers of inflammation and improve insulin sensitivity in obese women. J Am Geriatr Soc. 2014 Apr;62(4):607-14. doi: 10.1111/jgs.12749. Epub 2014 Mar 17.

  • Prior SJ, Blumenthal JB, Katzel LI, Goldberg AP, Ryan AS. Increased skeletal muscle capillarization after aerobic exercise training and weight loss improves insulin sensitivity in adults with IGT. Diabetes Care. 2014 May;37(5):1469-75. doi: 10.2337/dc13-2358. Epub 2014 Mar 4.

  • Yang RZ, Blumenthal JB, Glynn NM, Lee MJ, Goldberg AP, Gong DW, Ryan AS. Decrease of circulating SAA is correlated with reduction of abdominal SAA secretion during weight loss. Obesity (Silver Spring). 2014 Apr;22(4):1085-90. doi: 10.1002/oby.20657. Epub 2013 Dec 6.

  • Ryan AS, Li G, Blumenthal JB, Ortmeyer HK. Aerobic exercise + weight loss decreases skeletal muscle myostatin expression and improves insulin sensitivity in older adults. Obesity (Silver Spring). 2013 Jul;21(7):1350-6. doi: 10.1002/oby.20216. Epub 2013 May 19.

MeSH Terms

Conditions

ObesityInsulin ResistanceSedentary BehaviorMotor Activity

Interventions

Diet TherapyExercise

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesBehavior

Intervention Hierarchy (Ancestors)

Nutrition TherapyTherapeuticsMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Alice S. Ryan, PhD

    University of Maryland, VA Research Service

    PRINCIPAL INVESTIGATOR
  • Andrew P. Goldberg, MD

    University of Maryland, VA Research Service

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
NIH

Study Record Dates

First Submitted

April 15, 2009

First Posted

April 16, 2009

Study Start

March 1, 2002

Primary Completion

December 1, 2008

Study Completion

December 1, 2008

Last Updated

January 13, 2010

Record last verified: 2010-01

Locations